We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$87.5B
AUM Growth
+$6.24B
Cap. Flow
-$2.46B
Cap. Flow %
-2.82%
Top 10 Hldgs %
10.13%
Holding
4,337
New
572
Increased
1,477
Reduced
1,498
Closed
412

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$546M
2
AMZN icon
Amazon
AMZN
+$515M
3
TSLA icon
Tesla
TSLA
+$389M
4
NFLX icon
Netflix
NFLX
+$322M
5
ADBE icon
Adobe
ADBE
+$305M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$836M
2
CELG
Celgene Corp
CELG
+$460M
3
NVDA icon
NVIDIA
NVDA
+$429M
4
COP icon
ConocoPhillips
COP
+$311M
5
BIIB icon
Biogen
BIIB
+$301M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 11.75%
3 Healthcare 9.92%
4 Financials 7.86%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBNK
4251
DELISTED
United Financial Bancorp, Inc.
UBNK
-94,148
Closed -$1.28M
CJ
4252
DELISTED
C&J Energy Services, Inc.
CJ
-645,484
Closed -$6.93M
CVRS
4253
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
-1,995,883
Closed -$8.54M
MDSO
4254
CALL
DELISTED
Medidata Solutions, Inc.
MDSO
-10,000
Closed -$915K
RTEC
4255
DELISTED
Rudolph Technologies Inc
RTEC
-615,606
Closed -$16.2M
ALDR
4256
DELISTED
Alder Biopharmaceuticals
ALDR
-68,923
Closed -$1.3M
ISCA
4257
DELISTED
International Speedway Corp
ISCA
-91,113
Closed -$4.1M
DMTKW
4258
DELISTED
DermTech, Inc. Warrant
DMTKW
-450,000
Closed -$54K
NCI
4259
DELISTED
Navigant Consulting, Inc.
NCI
-12,071
Closed -$337K
TYPE
4260
DELISTED
Monotype Imaging Holdings Inc.
TYPE
-334,246
Closed -$6.62M
VSM
4261
DELISTED
Versum Materials, Inc.
VSM
-489,418
Closed -$25.9M
BID
4262
DELISTED
Sotheby's
BID
-220,308
Closed -$12.6M
DTV
4263
DELISTED
DTE Energy Company 2016 Corporate Units
DTV
-50,000
Closed -$2.89M
GNCA
4264
DELISTED
Genocea Biosciences, Inc.
GNCA
-10,747
Closed -$31K
DHXM
4265
DELISTED
DHX Media Ltd. Common Voting and Variable Voting Shares
DHXM
-225,100
Closed -$325K
ZGNX
4266
PUT
DELISTED
Zogenix, Inc.
ZGNX
-30,000
Closed -$1.2M
GTT
4267
PUT
DELISTED
GTT Communications, Inc.
GTT
-40,000
Closed -$377K
BEAT
4268
CALL
DELISTED
BioTelemetry, Inc.
BEAT
-20,000
Closed -$815K
CTIC
4269
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-21,396
Closed -$18K
SIVB
4270
DELISTED
SVB Financial Group
SIVB
-57,653
Closed -$13.1M
UBA
4271
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
-12,468
Closed -$295K
REV
4272
DELISTED
Revlon, Inc.
REV
-17,373
Closed -$408K
MBT
4273
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
-27,532
Closed -$223K
QIWI
4274
DELISTED
QIWI PLC
QIWI
-31,594
Closed -$693K
VEDL
4275
PUT
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
-50,000
Closed -$434K

Similar funds

D.E. Shaw & Co's Q4 2019 Portfolio in Review

As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
  • D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
  • D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
  • D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
  • D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
  • D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
  • D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.